期刊文献+

胶质瘤切除术对神经胶质瘤患者外周血淋巴细胞亚群及CD4^+CD25^+调节性T细胞的影响 被引量:4

在线阅读 下载PDF
导出
摘要 目的检测神经胶质瘤患者胶质瘤切除前后外周血淋巴细胞亚群及CD4+CD25+调节性T细胞,以期提供胶质瘤治疗的新思路。方法采用流式细胞术检测神经胶质瘤患者胶质瘤切除前后及正常人外周血中CD3+、CD3+CD4+、CD3+CD8+、CD4/CD8、CD3-CD16+/CD56+、CD3+HLA-DR+和CD4+CD25+调节性T细胞水平。结果与对照组比较,胶质瘤组CD4+/CD8+比值、CD3+CD4+、CD3-CD19+、CD3-CD16+/CD56+和CD3+HLA-DR+细胞百分比明显降低(P<0.05),CD3+细胞及百分比降低,但无显著性差异(P>0.05),CD3+CD8+细胞有所升高,但无显著性差异(P>0.05),CD4+CD25+明显升高(P<0.05);与胶质瘤切除术前组比较,术后组CD4+/CD8+比值、CD3+CD4+、CD3-CD16+/CD56+、CD3+HLA-DR+细胞百分比明显升高(P<0.05),CD3+细胞及CD3-CD19+百分比升高,但无显著性差异(P>0.05),CD3+CD8+、CD4+CD25+明显降低(P<0.05)。结论手术切除胶质瘤能明显降低CD4+CD25+调节性T细胞水平,减少对其他淋巴细胞的抑制作用,如同时辅以CD25抗体来清除掉一部分调节细胞也许会更进一步减少其对机体免疫功能的抑制,这或许为胶质瘤的治疗提供了一个新途径。
出处 《黑龙江医学》 2013年第4期241-244,共4页 Heilongjiang Medical Journal
基金 黑龙江省教育厅基金资助项目(11521105)
  • 相关文献

参考文献10

  • 1Feng X,Li B,Ye H. Increased frequency of CD4 + CD25 (high) FoxP3 + regulatory T cells in patients with hepatocellular carcinoma[J].Archivum Immunologiae et Therapiae Experimentalis,2011,(04):309-314.
  • 2Xu T,Duan Q,Wang G. CD4+CD25 high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy[J].Cell Biochemistry and Biophysics,2011,(02):389-392.
  • 3Karag(o)z B,Bilgi O,Gümüs M. CD8+CD28-cells and CD4 + CD25 + regulatory T cells in the peripheral blood of advanced stage lung cancer patients[J].Medical Oncology,2010,(01):29-33.
  • 4Elodie Vauleon,Tony Avril,Brigitte Collet. Overview of cellular immunotherapy for patients with Glioblastoma[J].CLINICAL & DEVELOPMENTAL IMMUNOLOGY,2010.
  • 5马学华,张萱,张娜,赵宇,宋丽婷.强直性脊柱炎患者外周血淋巴细胞亚群的检测及其临床意义[J].中国实验诊断学,2011,15(10):1765-1766. 被引量:8
  • 6牟永告,邓星海,严苏丽,魏大年,赛克,谢海涛,张湘衡,王振宁,李刚,刘铁坚,陈忠平.脑胶质瘤患者T淋巴细胞亚群检测的临床意义[J].中华神经医学杂志,2009,8(12):1244-1247. 被引量:7
  • 7Sakaguchi S,Sakaguchi N,Asano M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25)[J].Journal of Immunology,1995,(03):1151-1164.
  • 8Bach J F,Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes[J].Annual Review of Immunology,2001,(01):131-161.
  • 9Ghiringhelli F,Puig P E,Roux S. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25 + regulatory T cell proliferation[J].Journal of Experimental Medicine,2005,(07):919-929.
  • 10Fecci P E,Sweeney A E,Grossi P M. Systemic anti-CD25 monoclonal antibody administration safely enhances immunityin murine glioma without eliminating regulatory T cells[J].Clinical Cancer Research,2006,(14 Pt 1):4294-4305.

二级参考文献15

  • 1马莉,顾健,汪中强,吴蔚.流式细胞术检测SLE患者甲强龙冲击前、后淋巴细胞亚群的变化[J].标记免疫分析与临床,2005,12(4):259-260. 被引量:2
  • 2Ashby LS, Shapiro WR. Low-grade glioma: supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults[J]. Curr Neurol Neurosci Rep, 2004, 4(3): 211-217.
  • 3Stupp R, Mason WP, van den Brent MJ. et al. Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma[J]. N Engl J Med, 2005, 352: 987-996.
  • 4Alisa A, Boswell S, Pathan AA, et al. Human CD4 (+) T cells recognize an epitope within alpha-fetoprotein sequence and develop into TGF-beta-producing CD4 (+) T cells[J]. J Immunol, 2008, 180(7): 5109-5117.
  • 5Ehi K, Ishigami S, Masamoto I, et al. Analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells of sentinel lymph nodes in breast cancer[J]. Oncol Rep, 2008, 19(3): 601-607.
  • 6Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures[J]. J Clin Oncol, 2008, 26(27): 4410-4417.
  • 7Holladay FP, Heitz T, Wood GW. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lympho-cytes, but not by lymphokine-activated killer cells [J]. J Neurosurg, 1992, 77(5): 757-762.
  • 8Kempuraj D, Devi RS, Madhappan B, et al. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors [J]. Int J lmmtmopathol Pharmacol, 2004, 17(1): 57-64.
  • 9Almand B, Clark JI, Nikitina E, et al.Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer [J]. J Immunol, 2001, 166 (1): 678-679.
  • 10Pamey IF. Hao CH, Petruk KC. Glioma Immunology and Immunotherapy[J]. Crit Rev Immtmol, 2009, 29( 1): 1-42.

共引文献13

同被引文献35

  • 1李进东,许金良,王文光,赵婷茹,马杰.肺癌患者外周血T淋巴细胞亚群的变化[J].中国医师进修杂志(外科版),2006,29(11):25-27. 被引量:24
  • 2宁军,龚浩.中晚期肿瘤患者T淋巴细胞和NK细胞检测的临床意义[J].实用全科医学,2007,5(7):587-588. 被引量:12
  • 3赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 4Kobayashi E,Mizukoshi E,Kishi H,et al. A new cloning and expression system yields and validates TCRs from blood lynx pbocytes of patients with cancer within 10 days [J].Natur Medicine, 2013,19(11) 1542-1546.
  • 5Yang S,Karne NK,Goff SL,et al. A simple and effective meth od to generate lentiviral vectors for exvivo gene delivery to ma ture human peripheral blood lymphocytes[J].Human Gen< Therapy, 2012,23 (2) : 73-83.
  • 6高广禄.化疗联合同步放疗在晚期宫颈癌中的应用价值[J].中国保健营养·下旬刊,2014,24(1):53-54.
  • 7Durante M, Reppingen N, Held KD. Immunologically augmented cancer treatment using modern radiotherapy [ J ]. Trends in Molec- ular Medicine,2013,19 (9) :565 - 582.
  • 8Park B, Yee C, Lee KM. The effect of radiation on the immune re- sponse to cancers [ J ]. International J Molecular Sciences,2014, 15 ( 1 ) :927 - 943.
  • 9Frey B, Rubner Y, Kulzer L, et al. Antitumor immune responses induced by ionizing irradiation and further immune stimulation [ J]. Cancer Immunol Immunother,2014,63 ( 1 ) :29 - 36.
  • 10邬露丹,徐炜峰,熊逸群.恶性肿瘤患者淋巴细胞亚群的测定及与癌胚抗原的关系[J].实验与检验医学,2008,26(1):57-58. 被引量:10

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部